These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Apoptosis and oxidants in the heart. Kumar D; Jugdutt BI J Lab Clin Med; 2003 Nov; 142(5):288-97. PubMed ID: 14647032 [TBL] [Abstract][Full Text] [Related]
7. Programmed necrosis in heart disease: Molecular mechanisms and clinical implications. Zhu H; Sun A J Mol Cell Cardiol; 2018 Mar; 116():125-134. PubMed ID: 29426003 [TBL] [Abstract][Full Text] [Related]
8. Acute myocardial infarction and heart failure: role of apoptosis. Abbate A; Bussani R; Amin MS; Vetrovec GW; Baldi A Int J Biochem Cell Biol; 2006; 38(11):1834-40. PubMed ID: 16781883 [TBL] [Abstract][Full Text] [Related]
9. Apoptosis and heart failure: mechanisms and therapeutic implications. Chen QM; Tu VC Am J Cardiovasc Drugs; 2002; 2(1):43-57. PubMed ID: 14727998 [TBL] [Abstract][Full Text] [Related]
10. Cell death in the pathogenesis of heart disease: mechanisms and significance. Whelan RS; Kaplinskiy V; Kitsis RN Annu Rev Physiol; 2010; 72():19-44. PubMed ID: 20148665 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis in cardiovascular diseases: mechanism and clinical implications. Kim NH; Kang PM Korean Circ J; 2010 Jul; 40(7):299-305. PubMed ID: 20664736 [TBL] [Abstract][Full Text] [Related]
12. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure. Valen G Basic Res Cardiol; 2004 Jan; 99(1):1-7. PubMed ID: 14685699 [TBL] [Abstract][Full Text] [Related]
13. Phospholipid-mediated signaling systems as novel targets for treatment of heart disease. Tappia PS Can J Physiol Pharmacol; 2007 Jan; 85(1):25-41. PubMed ID: 17487243 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of AIF-mediated caspase-independent programmed cell death. Lorenzo HK; Susin SA Drug Resist Updat; 2007 Dec; 10(6):235-55. PubMed ID: 18180198 [TBL] [Abstract][Full Text] [Related]
15. Therapeutical perspectives for apoptosis modulation in cardiovascular disease. Ginghină C; Crăciunescu I; Iorga V Rom J Intern Med; 2006; 44(3):213-22. PubMed ID: 18386601 [TBL] [Abstract][Full Text] [Related]
16. The Cardioprotective Effects of Hydrogen Sulfide in Heart Diseases: From Molecular Mechanisms to Therapeutic Potential. Shen Y; Shen Z; Luo S; Guo W; Zhu YZ Oxid Med Cell Longev; 2015; 2015():925167. PubMed ID: 26078822 [TBL] [Abstract][Full Text] [Related]
17. Application of zinc-bis-(DL-hydrogensaspartate) does not reduce apoptotic cell death in myocardial infarction in the rat heart. Schwarz ER; Tussing T; Skobel E; Klosterhalfen B; Domanski D; Fuess JE J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):215-21. PubMed ID: 19605571 [TBL] [Abstract][Full Text] [Related]
19. [Effects of caspase-3 inhibitor on the neuronal apoptosis in rat cerebral cortex after ischemia-reperfusion injury]. Yu SZ; Yan L; Wang Q; An TL; Guan XQ Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):165-70. PubMed ID: 16630506 [TBL] [Abstract][Full Text] [Related]
20. Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection. Barlaka E; Galatou E; Mellidis K; Ravingerova T; Lazou A Cardiovasc Ther; 2016 Feb; 34(1):37-48. PubMed ID: 26589375 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]